The Omicron variant was isolated less than a month ago in Botswana, but Pfizer claims its existing booster provides the missing protection that the “vaccines” lack. This is an extraordinarily suspect claim that requires further investigation.
“Preliminary lab studies show two doses of the Pfizer/BioNTech vaccine may not provide sufficient protection against the Omicron coronavirus variant, but three doses are able to neutralize it, the companies said in a news release on Wednesday,” CNN uncritically reported.
“Samples from people who had two doses of the Covid-19 vaccine saw, on average, a more than 25-fold reduction in neutralization ability against the Omicron variant than the earlier virus, ‘indicating that two doses of BNT162b2 may not be sufficient to protect against infection with the Omicron variant,’ CNN cited the companies as saying.
This is quite the admission that the prior “vaccines” do almost nothing to stop the spread of the Omicron variant. This is what Pfizer is claiming the “preliminary” data show, according to its release.
- Preliminary laboratory studies demonstrate that three doses of the Pfizer-BioNTech COVID-19 Vaccine neutralize the Omicron variant (B.1.1.529 lineage) while two doses show significantly reduced neutralization titers
- Data indicate that a third dose of BNT162b2 increases the neutralizing antibody titers by 25-fold compared to two doses against the Omicron variant; titers after the booster dose are comparable to titers observed after two doses against the wild-type virus which are associated with high levels of protection
- As 80% of epitopes in the spike protein recognized by CD8+ T cells are not affected by the mutations in the Omicron variant, two doses may still induce protection against severe disease
- The companies continue to advance the development of a variant-specific vaccine for Omicron and expect to have it available by March in the event that an adaption is needed to further increase the level and duration of protection – with no change expected to the companies’ four billion dose capacity for 2022
“Although two doses of the vaccine may still offer protection against severe disease caused by the Omicron strain, it’s clear from these preliminary data that protection is improved with a third dose of our vaccine,” said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. “Ensuring as many people as possible are fully vaccinated with the first two dose series and a booster remains the best course of action to prevent the spread of COVID-19.”
This is an absolute lie. It should be no surprise that a Big Pharma CEO would lie about his product. But the U.S. government and the corporate press turning a blind eye to it on an issue of major public importance should have Americans outraged.
As was stated in court documents in a lawsuit against the FDA this week, the “vaccines” have absolutely failed in preventing the spread of Covid-19. Thus, there is no public health justification to mandate them or require them for travel.
“The pandemic is continuing to spiral. Despite over 83% of adults having received a COVID-19 vaccine, cases are on the rise in the most vaccinated states, variants that evade vaccine immunity are rising, the CDC has admitted the COVID-19 vaccines do not prevent transmission, the number of breakthrough cases is increasing exponentially, and boosters are now needed for everyone and will likely continue to be required every six months, if not more frequently, among numerous other issues with the vaccine program,” the lawyers for Public Health and Medical Professionals for Transparency argued.
As was earlier reported, Big Pharma companies announced that they were “confident” that they could rapidly develop a vaccine for the Omicron variant. Pfizer-BioNTech went so far as to float the idea of a vaccine “re-launch.”
But as medical researchers have found, Omicron is a “generally mild” variant that is extremely mutated from the original strain.
“Covid symptoms linked to the new omicron variant have been described as ‘extremely mild’ by the South African doctor who first raised the alarm over the new strain,” CNBC reported.
Yet, Pfizer is touting the necessity of a “booster” shot for a virus that is being compared to a Common Cold coronavirus. This is the Brave New World we are in.
It is extraordinarily suspect how the Pfizer “booster” somehow neutralizes a variant that has just arisen on an African continent that has been spared the Covid-19 virus contagion. (It is believed that this is due in part to widespread use of anti-malarial drugs that have retroviral capabilities.)
But due to “booster hesitancy” among millions who were burned the first time by pharmaceutical companies lying about the purported “vaccines,” Pfizer apparently has a solution that is all-too-perfect.
One month after the Omicron variant is “discovered,” Pfizer says that its booster completely remedies the vaccines‘ lack of effectiveness.
Isn’t that convenient?
The Wildfire Newsletter is a free and paid subscription service provided by independent journalist Kyle Becker. Never miss an issue!
This story syndicated with permission from Trending Politics